Cypress Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,800
Closed -$216K 160
2018
Q3
$216K Sell
2,800
-250
-8% -$18.9K 0.06% 172
2018
Q2
$216K Sell
3,050
-14,580
-83% -$1.03M 0.06% 171
2018
Q1
$1.33M Sell
17,630
-1,105
-6% -$87.8K 0.39% 79
2017
Q4
$1.34M Sell
18,735
-2,390
-11% -$181K 0.29% 92
2017
Q3
$1.71M Sell
21,125
-5,090
-19% -$389K 0.37% 79
2017
Q2
$1.85M Sell
26,215
-5,404
-17% -$360K 0.38% 71
2017
Q1
$2.15M Sell
31,619
-4,010
-11% -$282K 0.41% 68
2016
Q4
$2.55M Sell
35,629
-645
-2% -$47.9K 0.49% 61
2016
Q3
$2.87M Sell
36,274
-725
-2% -$58.9K 0.57% 54
2016
Q2
$3.09M Sell
36,999
-1,365
-4% -$121K 0.61% 50
2016
Q1
$3.52M Sell
38,364
-2,441
-6% -$220K 0.72% 48
2015
Q4
$4.13M Sell
40,805
-360
-0.9% -$37.5K 0.83% 40
2015
Q3
$4.04M Buy
41,165
+350
+0.9% +$38.9K 0.85% 43
2015
Q2
$4.78M Buy
40,815
+400
+1% +$43.7K 0.9% 37
2015
Q1
$3.97M Buy
40,415
+380
+0.9% +$38.6K 0.74% 46
2014
Q4
$3.77M Buy
40,035
+2,740
+7% +$283K 0.69% 51
2014
Q3
$3.97M Buy
37,295
+875
+2% +$85.7K 0.72% 48
2014
Q2
$3.02M Buy
36,420
+9,137
+33% +$711K 0.52% 60
2014
Q1
$1.93M Buy
+27,283
New +$2.14M 0.35% 79

Other funds holding GILD

Cypress Asset Management's GILD Position: Q4 2018 in Review

Cypress Asset Management sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 2,800 shares — an estimated $216K sold.

Cypress Asset Management first reported a position in GILD in Q1 2014 and held it in 19 quarters. The position peaked at $4.78M in Q2 2015. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Cypress Asset Management reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Cypress Asset Management sold 2,800 Gilead Sciences shares in Q4 2018, an estimated $216K.
  • Cypress Asset Management first reported a position in Gilead Sciences in Q1 2014 and held it in 19 quarters.
  • Cypress Asset Management's Gilead Sciences position peaked at $4.78M in Q2 2015.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Cypress Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.